Product improvement engineering efforts necessary to expand MHS genesis capabilities to include, a pharmacy BI-directional interface, accession community configurations, dental provider selection…

Ended Awarded Last action

Contract number
HT003819F0003
Awardee
Awarding agency
Obligated
$16,714,634

Award facts

Contract value 100% obligated
$16,714,634.01 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Incentive
Place of performance
Reston, VA 20190, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00009 -$3,100,246
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Other Administrative Action P00006 · Product improvement engineering to support integration efforts for new capabilities into MHS genesis. $0
Other Administrative Action P00005 · Product improvement engineering to add functionality to MHS genesis including referral management 2.0, BI-directional pharmacy interfaces, and additional health… $0
Change Order P00004 · Product improvement engineering to configure, integrate, and baseline new capabilities for MHS genesis. $10,919,940
Other Administrative Action P00003 · Product improvement engineering services to enable the capabilities in MHS genesis known as the apple PIE release. $5,526,560
Supplemental Agreement for work within scope P00002 · Product improvement engineering to implement new capability release known as "apple PIE". $1,369,140
Change Order P00001 · Product improvement engineering for the MHS genesis release of capabilities referred to as "apple PIE". $0
Original award $1,999,240

About this award

This is a $16,714,634.01 delivery order contract awarded by the Defense Health Agency to Leidos, Inc. to provide product improvement engineering efforts to expand the capabilities of the Military Health System (MHS) GENESIS. The efforts include integrating a pharmacy bi-directional interface, configuring the system for the accession community, automating dental provider selection, enhancing referral management, upgrading functional capabilities, and enabling private sector health exchange connectivity. This contract is not set aside for any small business categories. Leidos serves as the prime contractor, with subcontractors including Holland Square Group, ManTech Advanced Systems International, Valytics, Accenture Federal Services, and Cerner Corporation providing various technical services and solutions in support of the contract's objectives.

Description

Product improvement engineering efforts necessary to expand MHS genesis capabilities to include, a pharmacy BI-directional interface, accession community configurations, dental provider selection automation, customization for referral management 2.0, millennium .23 upgrade selected functional enhancements, and private sector health exchange.

Quick answers

Who was awarded contract HT003819F0003?

HT003819F0003 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on December 11, 2018.

How much is contract HT003819F0003 worth?

The government has obligated $16,714,634 on HT003819F0003.

Is contract HT003819F0003 an order under another contract?

Yes. HT003819F0003 is a delivery order under N0003915D0044, an indefinite delivery contract.

Was contract HT003819F0003 competed?

The extent of competition for HT003819F0003 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award